Back | Next |
home / stock / incy / incy message board
Subject | By | Source | When |
---|---|---|---|
Sold @ $90.50 to take profits. Has moved | chmcnfunds | investorshub | 03/05/2018 7:47:53 PM |
Back in $INCY @ $81.85. 52 week low. | chmcnfunds | investorshub | 03/01/2018 3:13:30 PM |
So glad sold @ $89.10 yesterday toward the | chmcnfunds | investorshub | 02/15/2018 2:38:12 PM |
How Incytes Jakafi Performed in 3Q17 | chmcnfunds | investorshub | 01/10/2018 1:43:12 PM |
Was thinking the same. Hope this will pass | chmcnfunds | investorshub | 01/09/2018 6:59:26 PM |
Herve made it clear that being taken over | hogar | investorshub | 01/09/2018 6:04:51 PM |
CEO interview: | chmcnfunds | investorshub | 01/09/2018 1:24:36 PM |
FWIW: Jim Cramer Advises His Viewers On Incyte And | chmcnfunds | investorshub | 01/08/2018 1:40:35 PM |
Incyte and Syros Announce Global Target Discovery and | chmcnfunds | investorshub | 01/08/2018 1:30:23 PM |
As long as they don't turn out like $KATX. | Spudskie | investorshub | 12/22/2017 9:53:22 PM |
3 Promising Cancer Immunotherapies to Watch in 2018 | chmcnfunds | investorshub | 12/22/2017 3:32:38 PM |
Biotech Pullback Makes Bargains Out Of Alexion, Flexion, | chmcnfunds | investorshub | 11/29/2017 5:09:11 PM |
In Incyte for the 1st time @ $99.25. | chmcnfunds | investorshub | 11/21/2017 3:04:23 PM |
https://seekingalpha.com/article/4124190-bristol-myers-squibb-brings-ace-card-mi | Inoviorulez | investorshub | 11/13/2017 2:21:18 PM |
I have seen no evidence to support that | north40000 | investorshub | 10/25/2017 7:04:08 PM |
$INCYs own PD-1 candidate (#msg-116696022) is apparently dead. | DewDiligence | investorshub | 10/25/2017 4:02:32 PM |
MGNX/$INCY deal is + for both, so far today. | north40000 | investorshub | 10/25/2017 3:05:20 PM |
Not so surprising....One expects a fairly high failure | shub | investorshub | 08/01/2017 6:58:24 PM |
They stopped some trials: | DewDiligence | investorshub | 08/01/2017 6:53:00 PM |
Let's see here; We've got a pipeline full | shub | investorshub | 08/01/2017 6:34:39 PM |
News, Short Squeeze, Breakout and More Instantly...
Incyte (Nasdaq: INCY) today announced that several abstracts featuring data from its oncology portfolio will be presented at the upcoming 2024 American Society of Clinical Oncology (ASCO) Annual Meeting held May 31 – June 4 in Chicago, and at the European Hematology Association 2024 (EHA20...
U.S. stocks were higher, with the Dow Jones gaining more than 90 points on Monday. Shares of GameStop Corp. (NYSE:GME) rose sharply during Monday...
Incyte commences Dutch Auction tender offer to repurchase up to $1.67 billion of outstanding common shares Incyte Corporation (Nasdaq:INCY) (the “Company”) today announced that its Board of Directors approved a share repurchase authorization of $2.0 billion. The Compan...